Brief: Cardiol Therapeutics Announces Massachusetts General Hospital As The 8th Major Medical Centre Participating In Maveric-Pilot
05/12/2023 13:11
Dec 5 (Reuters) - Cardiol Therapeutics Inc CRDL.TO :
* CARDIOL THERAPEUTICS INC - ANNOUNCES MASSACHUSETTS GENERAL
HOSPITAL AS THE 8TH MAJOR MEDICAL CENTRE PARTICIPATING IN
MAVERIC-PILOT
* CARDIOL THERAPEUTICS - MAVERIC-PILOT IS A PHASE II STUDY
IN
RECURRENT PERICARDITIS AND IS ANTICIPATED TO COMPLETE PATIENT
RECRUITMENT DURING Q1 2024
Source text for Eikon: ID:
Further company coverage: CRDL.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiol Therapeutics
See all newsBrief: Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy
Brief: Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus
Brief: Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis
NASDAQ RESUMED AT 09:00 AM